(Q41920369)

14 October 2017

title

Intralesional immunotherapy of malignant melanoma with mycobacterium smegmatis cell wall skeleton combined with trehalose dimycolate (P3) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A476567

5 July 2022

Intralesional immunotherapy of malignant melanoma with mycobacterium smegmatis cell wall skeleton combined with trehalose dimycolate (p3) (English)

1 reference

10.1002/1097-0142(197908)44:2<495::AID-CNCR2820440220>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C495::AID-CNCR2820440220%3E3.0.CO;2-B

10.1002/1097-0142(197908)44:2<495::AID-CNCR2820440220>3.0.CO;2-B

2 June 2023

main subject

alpha,alpha-trehalose

0 references

1 reference

1 reference

Mycobacterium smegmatis

object named as

mycobacterium smegmatis

1 reference

1 reference

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C495::AID-CNCR2820440220%3E3.0.CO;2-B

2 June 2023

author name string

G. J. Vosika

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A476567

5 July 2022

J. R. Schmidtke

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A476567

5 July 2022

A. Goldman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A476567

5 July 2022

E. Ribi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A476567

5 July 2022

R. Parker

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A476567

5 July 2022

G. R. Gray

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A476567

5 July 2022

language of work or name

English

0 references

publication date

1 August 1979

1 reference

full work available at URL

14 October 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197908)44:2%3C495::AID-CNCR2820440220%3E3.0.CO;2-B

1 reference

10.1002/1097-0142(197908)44:2<495::AID-CNCR2820440220>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C495::AID-CNCR2820440220%3E3.0.CO;2-B

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197908)44:2%3C495::AID-CNCR2820440220%3E3.0.CO;2-B

2 June 2023

1 reference

10.1002/1097-0142(197908)44:2<495::AID-CNCR2820440220>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C495::AID-CNCR2820440220%3E3.0.CO;2-B

2 June 2023

1 reference

14 October 2017

volume

44

1 reference

14 October 2017

issue

2

1 reference

14 October 2017

page(s)

495-503

1 reference

Complications of BCG vaccination in neoplastic disease

14 October 2017

cites work

1

1 reference

10.1002/1097-0142(197908)44:2<495::AID-CNCR2820440220>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C495::AID-CNCR2820440220%3E3.0.CO;2-B

Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3

2 June 2023

2

1 reference

10.1002/1097-0142(197908)44:2<495::AID-CNCR2820440220>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C495::AID-CNCR2820440220%3E3.0.CO;2-B

BCG and cancer (first of two parts).

2 June 2023

3

1 reference

10.1002/1097-0142(197908)44:2<495::AID-CNCR2820440220>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C495::AID-CNCR2820440220%3E3.0.CO;2-B

Cancer Immunology, Immunotherapy

2 June 2023

7

1

31

Florentin

1976

1 reference

10.1002/1097-0142(197908)44:2<495::AID-CNCR2820440220>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C495::AID-CNCR2820440220%3E3.0.CO;2-B

Cancer Immunology, Immunotherapy

2 June 2023

8

1

41

Getfard

1976

1 reference

10.1002/1097-0142(197908)44:2<495::AID-CNCR2820440220>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C495::AID-CNCR2820440220%3E3.0.CO;2-B

Nonspecific and specific immunosuppression in tumour-bearing mice by soluble immune complexes

2 June 2023

9

1 reference

10.1002/1097-0142(197908)44:2<495::AID-CNCR2820440220>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C495::AID-CNCR2820440220%3E3.0.CO;2-B

Brief Communication: Immunotherapy of Cancer: Tumor Suppression and Regression by Cell Walls of Mycobacterium phlei Attached to Oil Droplets2

2 June 2023

10

1 reference

10.1002/1097-0142(197908)44:2<495::AID-CNCR2820440220>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C495::AID-CNCR2820440220%3E3.0.CO;2-B

Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G.

2 June 2023

11

1 reference

10.1002/1097-0142(197908)44:2<495::AID-CNCR2820440220>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C495::AID-CNCR2820440220%3E3.0.CO;2-B

Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells

2 June 2023

12

1 reference

10.1002/1097-0142(197908)44:2<495::AID-CNCR2820440220>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C495::AID-CNCR2820440220%3E3.0.CO;2-B

Regression of pulmonary metastatic disease associated with intralesional BCG therapy of intracutaneous melanoma metastases

2 June 2023

13

1 reference

10.1002/1097-0142(197908)44:2<495::AID-CNCR2820440220>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C495::AID-CNCR2820440220%3E3.0.CO;2-B

Immunotherapy of melanoma with BCG: Two fatalities following intralesional injection

2 June 2023

14

1 reference

10.1002/1097-0142(197908)44:2<495::AID-CNCR2820440220>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C495::AID-CNCR2820440220%3E3.0.CO;2-B

Immunotherapy with nonviable microbial components

2 June 2023

17

1 reference

10.1002/1097-0142(197908)44:2<495::AID-CNCR2820440220>3.0.CO;2-B

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C495::AID-CNCR2820440220%3E3.0.CO;2-B

2 June 2023

Identifiers

10.1002/1097-0142(197908)44:2<495::AID-CNCR2820440220>3.0.CO;2-B

1 reference

14 October 2017

1 reference